MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
Saifudeen Ismael(University of Tennessee Health Science Center), Tauheed Ishrat(University of Tennessee Health Science Center)
Cited by 172
Related Papers
Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke
|Scientific Reports|2018|235
Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer’s Disease Brain
|Journal of Alzheimer s Disease|2019|108